DJIA 17,683.58 -46.53 -0.26%
NASDAQ 4,991.94 -17.27 -0.34%
S&P 500 2,068.76 -8.02 -0.39%
market minute promo

22.78 0.68 (3.08%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

HALO $22.78 3.08%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $21.93
Previous Close $22.10
Daily Range $21.71 - $22.87
52-Week Range $7.51 - $23.16
Market Cap $2.9B
P/E Ratio -48.04
Dividend (Yield) $0.00 (0.0%)
Volume 1,159,426
Average Daily Volume 1,600,312
Current FY EPS -$0.40

Sector

Healthcare

Industry

Drug Makers

Halozyme Therapeutics, Inc. (HALO) Description

A biopharmaceutical company dedicated to the development and commercialization of recombinant human enzymes for the drug delivery, palliative care, oncology and infertility markets. Website: http://www.halozyme.com/

News & Commentary

Why Shares in Halozyme Therapeutics, Inc. Are Soaring Higher

Halozyme Therapeutics, Inc. reported mid stage trial interim results showing that PEGPH20 may help patients with metastatic pancreatic cancer.

10 Best Biotech Stocks in the NASDAQ

New Lifetime High Today: Halozyme Therapeutics (HALO)

IBM Will Not Have A Great Quarter - Cramer's Lightning Round (6/25/15)

'Mad Money' Lightning Round: Stay Away From Las Vegas Sands

Trade-Ideas: Halozyme Therapeutics (HALO) Is Today's "Dead Cat Bounce" Stock

Halozyme Therapeutics (HALO) Hits New Lifetime High

Can Halozyme Therapeutics (HALO) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tap

Can Halozyme Therapeutics (HALO) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tape

Stocks Hitting 52-Week Highs

Schneider Electric Expands Its Partnership With OpenText To Enable Global Supply Chain Platform

Halozyme-AbbVie Ink Deal for ENHANZE Platform, Shares Up - Analyst Blog

See More HALO News...

HALO's Top Competitors

HALO $22.78 (3.08%)
Current stock: HALO
AMGN $154.50 (0.81%)
Current stock: AMGN
GILD $115.66 (0.54%)
Current stock: GILD
BIIB $404.63 (0.09%)
Current stock: BIIB